BioMérieux stock declines over 2% and falls back to its 20-day moving average
After breaking through a technical threshold the previous day, BioMérieux loses ground this Friday and finds itself among the biggest decliners of the SBF 120, while the index itself retreats slightly during the session. The in vitro diagnostics specialist thus erases part of the positive movement recorded the previous day, in a context of a globally cautious European market.
A decline of 2.17% that brings the stock back to its 20-day moving average
BioMérieux loses 2.17% to €74.30 during the session, after closing at €75.95 the previous day. This decline places the stock almost exactly at its 20-day MA of €74.03, a gap narrowed to +0.36%, a threshold it had broken upward during the previous session. The 50-day MA at €72.14 remains below the current price with a gap of nearly 3%, offering an intermediate floor in case the decline continues.
The 200-day MA still weighs at €86.63, or 14.23% above the current price, a sign that medium-term momentum remains deteriorated on this horizon. The RSI at 60 reflects a still bullish short-term configuration, without signaling overbought conditions, which leaves room before potential buyer exhaustion. The stock is among the biggest decliners of the SBF 120 during the session, in an index declining 0.34% to 6,261.44 points, in a context of a relatively calm market (VIX at 14.03).
Solid monthly performance despite a decline of over 36% year-over-year
Over the week, BioMérieux loses 1.59%, a decline that tempers a monthly gain of 2.84% and a quarterly rebound of nearly 5%. These short and medium-term performances contrast with the twelve-month trajectory: the stock is down 36.98% over one year, a decline that illustrates the distance remaining before a return to the 200-day MA. The support identified at €69.00 represents the next reference level in case of an acceleration of the decline, approximately 7% below the current price.
The resistance at €75.80, briefly broken the previous day according to Thursday's September 3 session movement, has moved back out of reach: this level will determine whether the stock can regain buying momentum at the end of the week or at the opening of the next one.
